Chemerin Is a Valuable Biomarker in Patients with HCV Infection and Correlates with Liver Injury

URN to cite this document:: urn:nbn:de:bvb:355-epub-442490
DOI to cite this document:: 10.5283/epub.44249

Peschel, Georg ; Grimm, Jonathan ; Gülow, Karsten ; Müller, Martina ; Buechler, Christa

; Weigand, Kilian

Preview

License: Creative Commons Attribution 4.0
PDF - Published Version
(929kB)

Date of publication of this fulltext: 14 Jan 2021 09:43

Alternative links to fulltext:DOI Publisher Publisher

Details

Preview

Indexed in

Export bibliographical data

Abstract

Hepatitis C virus (HCV)-induced inflammation contributes to progressive liver disease. The chemoattractant protein chemerin is associated with systemic inflammation. We hypothesized that chemerin is a biomarker that predicts the severity of liver disease in HCV patients. Furthermore, we investigated whether serum chemerin levels change during the course of HCV treatment using direct-acting ...